ClinConnect ClinConnect Logo
Search / Trial NCT06908512

Adaptation of the Intensive Care Unit-specific Pressure Injury Risk Scale to Turkish (RAPS-ICU)

Launched by HARRAN UNIVERSITY · Mar 26, 2025

Trial Information

Current as of July 23, 2025

Not yet recruiting

Keywords

Pressure Injury Reliability And Validity Intensive Care Units Assessment Scale

ClinConnect Summary

This clinical trial, called RAPS-ICU, is focused on adapting a special assessment tool designed to help identify the risk of pressure injuries (also known as bedsores) for patients in Intensive Care Units (ICUs) into Turkish. The goal is to ensure that this tool works well in a Turkish-speaking context by testing its reliability and how well it measures what it is supposed to measure. This will help healthcare providers better assess and prevent pressure injuries in ICU patients.

To participate in the study, individuals must be 18 years or older, have been in the ICU for at least one day, and be willing to join the study either themselves or through their family members. Participants should be fully aware of their surroundings and not have any psychiatric issues that affect their ability to communicate. This trial is currently not recruiting participants, but once it starts, those who join can expect to help improve the care of future patients in ICUs by contributing to important research.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 18 years of age or older,
  • Staying in the Intensive Care Unit for at least 1 day,
  • Agreeing to participate in the study by themselves or a family member.
  • Volunteering to participate in the research
  • Full orientation and no psychiatric problems
  • Exclusion Criteria:
  • - Having communication problems

About Harran University

Harran University is a distinguished academic institution committed to advancing healthcare through innovative research and clinical trials. With a focus on enhancing patient outcomes, the university leverages its multidisciplinary expertise to conduct rigorous scientific investigations. Harran University fosters collaboration among researchers, clinicians, and industry partners to explore novel therapeutic approaches and improve clinical practices. Through its dedication to ethical standards and patient safety, Harran University aims to contribute significantly to the body of medical knowledge and the development of effective treatments.

Locations

Sanliurfa, , Turkey

Patients applied

0 patients applied

Trial Officials

Ayşe Şahin, Assist. Prof.

Study Chair

Harran University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported